Safety and feasibility of breast lesion localization using magnetic seeds (Magseed): a multi-centre, open-label cohort study

被引:102
|
作者
Harvey, James R. [1 ]
Lim, Yit [1 ]
Murphy, John [1 ]
Howe, Miles [1 ]
Morris, Julie [1 ]
Goyal, Amit [2 ]
Maxwell, Anthony J. [1 ,3 ]
机构
[1] Univ Manchester, Wythenshawe Hosp, Univ Hosp South Manchester, Manchester Acad Hlth Sci Ctr,Nightingale Ctr, Southmoor Rd, Manchester M23 9LT, Lancs, England
[2] Royal Derby Hosp, Derby DE22 3NE, Derbyshire, England
[3] Univ Manchester, Fac Biol Med & Hlth, Sch Hlth Sci, Div Informat Imaging & Data Sci, Manchester M13 9PT, Lancs, England
关键词
Mastectomy; Breast cancer; Lumpectomy; Seed localization; Magnetic; BIOPSY;
D O I
10.1007/s10549-018-4709-y
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose Wire localization has several disadvantages, notably wire migration and difficulty scheduling the procedure close to surgery. Radioactive seed localization overcomes these disadvantages, but implementation is limited due to radiation safety requirements. Magnetic seeds potentially offer the logistical benefits and transcutaneous detection equivalence of a radioactive seed, with easier implementation. This study was designed to evaluate the feasibility and safety of using magnetic seeds for breast lesion localization. Methods A two-centre open-label cohort study to assess the feasibility and safety of magnetic seed (Magseed) localization of breast lesions. Magseeds were placed under radiological guidance into women having total mastectomy surgery. The primary outcome measure was seed migration distance. Secondary outcome measures included accuracy of placement, ease of transcutaneous detection, seed integrity and safety. Results Twenty-nine Magseeds were placed into the breasts of 28 patients under ultrasound guidance. There was no migration of the seeds between placement and surgery. Twenty-seven seeds were placed directly in the target lesion with the other seeds being 2 and 3 mm away. All seeds were detectable transcutaneously in all breast sizes and at all depths. There were no complications or safety issues. Conclusions Magnetic seeds are a feasible and safe method of breast lesion localization. They can be accurately placed, demonstrate no migration in this feasibility study and are detectable in all sizes and depths of breast tissue. Now that safety and feasibility have been demonstrated, further clinical studies are required to evaluate the seed's effectiveness in wide local excision surgery.
引用
收藏
页码:531 / 536
页数:6
相关论文
共 50 条
  • [1] Safety and feasibility of breast lesion localization using magnetic seeds (Magseed): a multi-centre, open-label cohort study
    James R. Harvey
    Yit Lim
    John Murphy
    Miles Howe
    Julie Morris
    Amit Goyal
    Anthony J. Maxwell
    [J]. Breast Cancer Research and Treatment, 2018, 169 : 531 - 536
  • [2] A multi-centre, open-label, prospective, observational study to assess the safety of a nifedipine oral solution in the treatment of preterm labor
    Murillo, C.
    Migliorelli, F.
    Nieto, C.
    Martinez, H.
    Rueda, C.
    Bermejo, R.
    Corrales, A.
    Palacio, M.
    [J]. CLINICA E INVESTIGACION EN GINECOLOGIA Y OBSTETRICIA, 2023, 50 (04):
  • [3] Magnetic guided localization for non-palpable breast lesion: A multi-center open-label trial in Japan
    Kurita, Tomoko
    Taruno, Kanae
    Nakamura, Seigo
    Takei, Hiroyuki
    Enokido, Katsutoshi
    Kuwayama, Takashi
    Kanada, Yoko
    Akashi, Sadako
    Nakai, Maki
    Hankyo, Meishi
    Yanagihara, Keiko
    Sakatani, Takashi
    Sakamaki, Kentaro
    Kuwahata, Akihiko
    Sekino, Masaki
    Kusakabe, Moriaki
    [J]. CANCER RESEARCH, 2020, 80 (04)
  • [4] The safety and efficacy of intravenous ferric carboxymaltose in anaemic patients undergoing haemodialysis: a multi-centre, open-label, clinical study
    Covic, Adrian
    Mircescu, Gabriel
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2010, 25 (08) : 2722 - 2730
  • [5] Effectiveness of quetiapine in bipolar depression patients: a multi-centre, prospective, open-label, observational study
    Jeong, J.
    Bahk, W. M.
    Woo, Y. S.
    Min, K. J.
    Jon, D. I.
    Yoon, B. H.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2010, 20 : S409 - S409
  • [6] Hepatitis A vaccine for immunosuppressed patients with rheumatoid arthritis: A prospective, open-label, multi-centre study
    Askling, Helena H.
    Rombo, Lars
    van Vollenhoven, Ronald
    Hallen, Ingemar
    Thorner, Ake
    Nordin, Margareta
    Herzog, Christian
    Kantele, Anu
    [J]. TRAVEL MEDICINE AND INFECTIOUS DISEASE, 2014, 12 (02) : 134 - 142
  • [7] A multi-centre, outpatient, open-label study to evaluate the dosing, effectiveness and safety of Topamax® as monotherapy in the treatment of epilepsy in clinical practice
    Sankar, R.
    Ramsay, E.
    Mckay, A.
    Zhu, Y.
    Hulihan, J.
    Wiegand, F.
    [J]. EPILEPSIA, 2007, 48 : 73 - 74
  • [8] Is the future magnetic? Magseed localisation for non palpable breast cancer. A multi-centre non randomised control study
    Zacharioudakis, Konstantinos
    Down, Sue
    Bholah, Zaheerah
    Lee, Sum
    Khan, Taherah
    Maxwell, Anthony J.
    Howe, Miles
    Harvey, James
    [J]. EJSO, 2019, 45 (11): : 2016 - 2021
  • [9] A Canadian multi-centre, open-label long-term study of Pegvisomant treatment in refractory acromegaly
    Ezzat, Shereen
    Gaspo, Rania
    Serri, Omar
    Ur, Ehud
    Chik, Constance L.
    [J]. CLINICAL AND INVESTIGATIVE MEDICINE, 2009, 32 (06): : E265 - E277
  • [10] Add-on levetiracetam in children and adolescents with refractory epilepsy: Results of an open-label multi-centre study
    Callenbach, Petra M. C.
    Arts, Willem Frans M.
    ten Houten, Robert
    Augustijn, Paul
    Gunning, W. Boudewijn
    Peeters, Els A. J.
    Weber, Alma M.
    Stroink, Hans
    Geerts, Yvette
    Geerts, Ada T.
    Brouwer, Oebele F.
    [J]. EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY, 2008, 12 (04) : 321 - 327